Development of a predictive miRNA signature for breast cancer risk among high-risk women.

about

Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.Circular RNA Complement Factor H (CFH) Promotes Glioma Progression by Sponging miR-149 and Regulating AKT1

P2860

Q52718880-F5F6AF7D-5221-4578-BA5A-651B48521D81 Q58773484-64989801-67C3-409C-A452-B70ADA68E610

P2860

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

Item

http://www.wikidata.org/entity/Q47724615

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@en

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@nl

type

Item

label

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@en

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@nl

prefLabel

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@en

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@nl

P1476

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

@en

P2093

David J Shirley

http://www.w3.org/2001/XMLSchema#string

Gary S Stein

http://www.w3.org/2001/XMLSchema#string

Jane B Lian

http://www.w3.org/2001/XMLSchema#string

Janet L Stein

http://www.w3.org/2001/XMLSchema#string

Jon E Ramsey

http://www.w3.org/2001/XMLSchema#string

Marie E Wood

http://www.w3.org/2001/XMLSchema#string

Melissa E Cuke

http://www.w3.org/2001/XMLSchema#string

Nicholas H Farina

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

Secretory mechanisms and intercellular transfer of microRNAs in living cells

Circulating microRNAs as stable blood-based markers for cancer detection.

microRNA Therapeutics in Cancer - An Emerging Concept

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Export of microRNAs and microRNA-protective protein by mammalian cells

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

Non-coding RNAs: regulators of disease

P304

112170-112183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22750

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas P Ahern

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29348816

http://www.w3.org/2001/XMLSchema#string

P932

5762501

http://www.w3.org/2001/XMLSchema#string

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

about

P2860

P2860

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932